84 results
Page 3 of 5
8-K
EX-99.1
zbpmst7p0pnasotd
15 Nov 22
Other Events
4:17pm
8-K
EX-99.1
e3s18ejawrvqxs0v0c
14 Nov 22
Immunome Reports Third Quarter 2022 Financial Results
9:06am
8-K
EX-99.1
bifwq167m6gu b1
5 Aug 22
Immunome Reports Second Quarter 2022 Financial Results
8:15am
8-K
EX-99.1
zy3s29tege6fq8dyb
6 Jul 22
Other Events
5:15pm
8-K
EX-99.1
bwx6zeejyipn4te4d
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am
8-K
EX-99.2
he7l6t
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am
8-K
EX-99.1
3etck92x
19 May 22
Other Events
4:05pm
8-K
EX-99.1
vu1iv9cust ik
12 May 22
Immunome Reports First Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
evi7oz
28 Mar 22
Immunome Reports Fourth Quarter and Full Year 2021 Financial Results
8:14am
8-K
EX-99.1
hujmvw
11 Mar 22
FDA Lifts Clinical Hold on Immunome’s IMM-BCP-01 IND Application for the Treatment of COVID-19
2:33pm
8-K
EX-99.1
fjpzwz33 dn2a
8 Feb 22
Other Events
8:27am
8-K
EX-99.1
q2w a86k9v
10 Jan 22
Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19
4:52pm
8-K
EX-99.1
8qi3x0vs9o9spjcpt
29 Nov 21
Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
7:14am
8-K
EX-99.1
pbeu7wonwueuw zw6m
18 Oct 21
Regulation FD Disclosure
4:27pm
S-3
ambbyhqj
1 Oct 21
Shelf registration
4:42pm
8-K
EX-99.1
prau9k3p s0ftckrg4n
21 Sep 21
Regulation FD Disclosure
7:40am